1. Home
  2. AXTI vs IRON Comparison

AXTI vs IRON Comparison

Compare AXTI & IRON Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo AXT Inc

AXTI

AXT Inc

HOLD

Current Price

$60.76

Market Cap

3.1B

Sector

Technology

ML Signal

HOLD

Logo Disc Medicine Inc.

IRON

Disc Medicine Inc.

HOLD

Current Price

$77.00

Market Cap

2.9B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
AXTI
IRON
Founded
1986
2017
Country
United States
United States
Employees
N/A
N/A
Industry
Semiconductors
Biotechnology: Pharmaceutical Preparations
Sector
Technology
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
3.1B
2.9B
IPO Year
1998
2020

Fundamental Metrics

Financial Performance
Metric
AXTI
IRON
Price
$60.76
$77.00
Analyst Decision
Hold
Strong Buy
Analyst Count
3
11
Target Price
$50.50
$103.18
AVG Volume (30 Days)
7.2M
441.7K
Earning Date
04-30-2026
05-07-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
$99,361,000.00
N/A
Revenue This Year
$44.70
N/A
Revenue Next Year
$42.23
$283.52
P/E Ratio
N/A
N/A
Revenue Growth
31.09
N/A
52 Week Low
$1.90
$40.00
52 Week High
$143.16
$99.50

Technical Indicators

Market Signals
Indicator
AXTI
IRON
Relative Strength Index (RSI) 49.91 51.85
Support Level $53.36 $70.29
Resistance Level $71.49 $82.65
Average True Range (ATR) 6.58 3.33
MACD 1.46 -0.16
Stochastic Oscillator 66.78 49.48

Price Performance

Historical Comparison
AXTI
IRON

About AXTI AXT Inc

AXT Inc is a developer and producer of compound and single element semiconductor substrates, also known as wafers. The dominant substrates used in producing semiconductor chips and other electronic circuits are made from silicon. It is engaged in the design, development, manufacture, and distribution of high-performance compound semiconductor substrates and the sale of materials. The company provides alternative or specialty materials in the form of substrates or wafers, including compound and single-element substrates. Its compound substrates combine indium with phosphorous or gallium with arsenic. Geographically firm has its business presence across the region of Europe, Japan, Taiwan, China, North America, and the Asia Pacific from which China derives its maximum revenue to the company.

About IRON Disc Medicine Inc.

Disc Medicine Inc is a clinical-stage biopharmaceutical company focused on the discovery, development, and commercialization of novel treatments for hematologic diseases. It aims to modify fundamental biological pathways associated with the formation and function of red blood cells, specifically heme biosynthesis and iron homeostasis. Its pipeline includes bitopertin for erythropoietic porphyrias (EPs), including erythropoietic protoporphyria (EPP), X-linked protoporphyria (XLP), and Diamond-Blackfan Anemia (DBA); DISC-0974 for the treatment of anemia of myelofibrosis (MF) and anemia of chronic kidney disease (CKD); and DISC-3405 for the treatment of polycythemia vera (PV) and other hematologic disorders. In addition, the Company's preclinical programs include DISC-0998.

Share on Social Networks: